201 related articles for article (PubMed ID: 25545452)
1. Synthesis and in vivo evaluation of gallium-68-labeled glycine and hippurate conjugates for positron emission tomography renography.
Pathuri G; Hedrick AF; January SE; Galbraith WK; Awasthi V; Arnold CD; Cowley BD; Gali H
J Labelled Comp Radiopharm; 2015 Jan; 58(1):14-9. PubMed ID: 25545452
[TBL] [Abstract][Full Text] [Related]
2. Primary radiation dosimetry of a novel PET radiopharmaceutical
Cheki M; Gali H
Hell J Nucl Med; 2017; 20(3):241-246. PubMed ID: 29177263
[TBL] [Abstract][Full Text] [Related]
3. Evaluating Ga-68 Peptide Conjugates for Targeting VPAC Receptors: Stability and Pharmacokinetics.
Kumar P; Tripathi SK; Chen CP; Wickstrom E; Thakur ML
Mol Imaging Biol; 2019 Feb; 21(1):130-139. PubMed ID: 29802552
[TBL] [Abstract][Full Text] [Related]
4. 68Ga-labeling and in vivo evaluation of a uPAR binding DOTA- and NODAGA-conjugated peptide for PET imaging of invasive cancers.
Persson M; Madsen J; Østergaard S; Ploug M; Kjaer A
Nucl Med Biol; 2012 May; 39(4):560-9. PubMed ID: 22172391
[TBL] [Abstract][Full Text] [Related]
5. In vivo imaging of folate receptor positive tumor xenografts using novel 68Ga-NODAGA-folate conjugates.
Fani M; Tamma ML; Nicolas GP; Lasri E; Medina C; Raynal I; Port M; Weber WA; Maecke HR
Mol Pharm; 2012 May; 9(5):1136-45. PubMed ID: 22497506
[TBL] [Abstract][Full Text] [Related]
6. Synthesis of novel gallium-68 labeled rhodamine: A potential PET myocardial perfusion agent.
Jammaz IA; Al-Otaibi B; Al-Hokbani N; Okarvi SM
Appl Radiat Isot; 2019 Feb; 144():29-33. PubMed ID: 30508730
[TBL] [Abstract][Full Text] [Related]
7. Radiolabeling and Preliminary Evaluation of Ga-68 Labeled NODAGA-Ubiquicidin Fragments for Prospective Infection Imaging.
Bhatt J; Mukherjee A; Korde A; Kumar M; Sarma HD; Dash A
Mol Imaging Biol; 2017 Feb; 19(1):59-67. PubMed ID: 27406090
[TBL] [Abstract][Full Text] [Related]
8. Preparation, Characterization, and Radiolabeling of [
Ashhar Z; Yusof NA; Ahmad Saad FF; Mohd Nor SM; Mohammad F; Bahrin Wan Kamal WH; Hassan MH; Ahmad Hassali H; Al-Lohedan HA
Molecules; 2020 Jun; 25(11):. PubMed ID: 32526838
[TBL] [Abstract][Full Text] [Related]
9. (64)Cu- and (68)Ga-Based PET Imaging of Folate Receptor-Positive Tumors: Development and Evaluation of an Albumin-Binding NODAGA-Folate.
Farkas R; Siwowska K; Ametamey SM; Schibli R; van der Meulen NP; Müller C
Mol Pharm; 2016 Jun; 13(6):1979-87. PubMed ID: 27145400
[TBL] [Abstract][Full Text] [Related]
10. NOTA and NODAGA [
Makris G; Radford LL; Kuchuk M; Gallazzi F; Jurisson SS; Smith CJ; Hennkens HM
Bioconjug Chem; 2018 Dec; 29(12):4040-4049. PubMed ID: 30412382
[TBL] [Abstract][Full Text] [Related]
11. Radiochemical synthesis and preclinical evaluation of
Hajdu I; Angyal J; Szikra D; Kertész I; Malanga M; Fenyvesi É; Szente L; Vecsernyés M; Bácskay I; Váradi J; Fehér P; Ujhelyi Z; Vasvári G; Rusznyák Á; Trencsényi G; Fenyvesi F
Eur J Pharm Sci; 2019 Feb; 128():202-208. PubMed ID: 30521943
[TBL] [Abstract][Full Text] [Related]
12. Benefit of Later-Time-Point PET Imaging of HER3 Expression Using Optimized Radiocobalt-Labeled Affibody Molecules.
Rinne SS; Dahlsson Leitao C; Saleh-Nihad Z; Mitran B; Tolmachev V; Ståhl S; Löfblom J; Orlova A
Int J Mol Sci; 2020 Mar; 21(6):. PubMed ID: 32183096
[TBL] [Abstract][Full Text] [Related]
13. Increase in negative charge of
Rinne SS; Dahlsson Leitao C; Gentry J; Mitran B; Abouzayed A; Tolmachev V; Ståhl S; Löfblom J; Orlova A
Sci Rep; 2019 Nov; 9(1):17710. PubMed ID: 31776413
[TBL] [Abstract][Full Text] [Related]
14. PET imaging of very late antigen-4 in melanoma: comparison of 68Ga- and 64Cu-labeled NODAGA and CB-TE1A1P-LLP2A conjugates.
Beaino W; Anderson CJ
J Nucl Med; 2014 Nov; 55(11):1856-63. PubMed ID: 25256059
[TBL] [Abstract][Full Text] [Related]
15. Comparison of Ga-68-Labeled Fusarinine C-Based Multivalent RGD Conjugates and [(68)Ga]NODAGA-RGD-In Vivo Imaging Studies in Human Xenograft Tumors.
Zhai C; Franssen GM; Petrik M; Laverman P; Summer D; Rangger C; Haubner R; Haas H; Decristoforo C
Mol Imaging Biol; 2016 Oct; 18(5):758-67. PubMed ID: 26905697
[TBL] [Abstract][Full Text] [Related]
16.
Vats K; Sharma R; Sarma HD; Satpati D; Dash A
Anticancer Agents Med Chem; 2018; 18(9):1289-1294. PubMed ID: 29546835
[TBL] [Abstract][Full Text] [Related]
17. In vivo preclinical evaluation of the new
Trencsényi G; Kis A; Szabó JP; Ráti Á; Csige K; Fenyvesi É; Szente L; Malanga M; Méhes G; Emri M; Kertész I; Vecsernyés M; Fenyvesi F; Hajdu I
Int J Pharm; 2020 Feb; 576():118954. PubMed ID: 31935470
[TBL] [Abstract][Full Text] [Related]
18. Molecular Design of HER3-Targeting Affibody Molecules: Influence of Chelator and Presence of HEHEHE-Tag on Biodistribution of
Dahlsson Leitao C; Rinne SS; Mitran B; Vorobyeva A; Andersson KG; Tolmachev V; Ståhl S; Löfblom J; Orlova A
Int J Mol Sci; 2019 Mar; 20(5):. PubMed ID: 30832342
[TBL] [Abstract][Full Text] [Related]
19. Development and Validation of an Analytical HPLC Method to Assess Chemical and Radiochemical Purity of [
Migliari S; Sammartano A; Boss M; Gotthardt M; Scarlattei M; Baldari G; Silva C; Bonadonna RC; Ruffini L
Molecules; 2022 Jan; 27(2):. PubMed ID: 35056858
[No Abstract] [Full Text] [Related]
20. Synthesis and preclinical evaluation of 68Ga-labeled collagelin analogs for imaging and quantification of fibrosis.
Velikyan I; Rosenström U; Estrada S; Ljungvall I; Häggström J; Eriksson O; Antoni G
Nucl Med Biol; 2014 Oct; 41(9):728-36. PubMed ID: 25023066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]